Purdue Pharma Settlement Payout Date and Schedule

The Purdue Pharma settlement payout date depends on who is being paid. The $7.4 billion deal became legally effective on May 1, 2026, which triggered the first payments from the Sackler family and Purdue’s estate to state and local governments. Individual personal injury claimants have not been paid yet. The claims administrator has said payments to qualified individual claimants could begin in the summer of 2026, though that timeline still depends on finishing eligibility reviews and resolving medical provider liens against individual awards.¹

When Individual Claimants Will Be Paid

The Purdue Personal Injury Trust is still working through submitted claims. The filing deadline was July 28, 2025, and any claim received more than 15 days after that date was disqualified. Between October 2025 and February 2026, the Trust mailed deficiency notices to claimants whose paperwork was incomplete or missing items like HIPAA consent forms, prescription records, or NAS diagnoses. Claimants had 30 days to cure any deficiencies.²

The Trust has said it will not send individual status updates or award information until after the plan’s Effective Date, which was projected to arrive no earlier than late March 2026.² According to the Trust’s FAQ, the PI Claims Administrator is aiming to begin payments in summer 2026, contingent on the Effective Date and lien resolution.¹

As of June 2026, no payments to individual personal injury claimants have been made. The Trust has not disclosed how many claims it received or how many have been approved.²

How Much Individual Claimants May Receive

The confirmed plan sets aside up to $865 million for individual victims. That pool covers both adults harmed by Purdue opioids and children born with neonatal abstinence syndrome.³ Per-person amounts are estimates and could change based on how many claims ultimately qualify.

For non-NAS adult claims, the Trust has published two tiers. Tier 1, which requires evidence of at least six months of prescribed use of a qualifying Purdue opioid before September 15, 2019, is estimated at roughly $16,000. Tier 2, requiring at least one day but less than six months of prescribed use, is estimated at about $8,000.¹ The Trust has warned that these figures are subject to “material change” once the final count of qualified claims is known.

Those numbers are a significant drop from earlier projections. Under the original bankruptcy plan struck down by the Supreme Court in 2024, payouts for a fatal OxyContin overdose were estimated at $48,000. The revised plan brought the minimum down to $8,000 and eliminated a prior option that let victims submit a sworn affidavit instead of medical records to prove they used Purdue products. The revised plan also cut compensation for teenagers who bought Purdue drugs without prescriptions.⁴

NAS claims involving children born with opioid withdrawal symptoms could pay less. Over 6,000 babies and children are part of the claims process, and advocacy groups have estimated many could receive as little as $3,500 before attorney fees, expert costs, and Medicaid lien deductions.⁵ Legal fees can further erode payouts. Some plaintiff firms hold contracts entitling them to up to 40% of an individual’s award.⁴

Payment Schedule for the $7.4 Billion Deal

The settlement became legally effective on May 1, 2026, which triggered the first round of payments from both the Sackler family and Purdue Pharma’s estate. The Sacklers paid more than $1.5 billion on that date, and Purdue contributed approximately $900 million.⁶ Additional Sackler installments are scheduled for approximately $500 million in May 2027, $500 million in May 2028, and $400 million in May 2029.⁷ The bulk of funds are expected to be distributed within the first three years, though the full payout stretches over 15 years.

The Sackler family’s total contribution is expected to reach $6.5 billion, with the possibility of an additional $500 million from the sale of international pharmaceutical businesses.³ Fifty-five attorneys general, representing all eligible U.S. states and territories, signed onto the settlement.⁷ Settlement funds directed to governments must be used for addiction treatment, prevention, and recovery.⁸ Federally recognized tribes are set to receive a separate $175 million payment.⁹

When States Will See Money

State timelines vary. Pennsylvania expects to receive more than $205 million over 15 years, with funds potentially flowing to the state and its subdivisions as early as late 2026.⁷ Maryland expects more than $90 million, managed through its Opioid Restitution Fund.⁶ Minnesota is set to receive $59 million, with 75% going to cities and counties and 25% to the state under a 2021 allocation agreement.¹⁰ California could receive up to $440 million, Texas up to $286.6 million, and New York up to $250 million over the full 15-year period.³ Washington State secured up to $122.2 million through settlement agreements with Purdue and eight generic opioid manufacturers, split evenly between state government and local jurisdictions.¹¹

How To Check on a Personal Injury Claim

The PI Claims Administrator is Ed Gentle. Claimants represented by an attorney should contact their law firm, since the Trust communicates with firms directly rather than with represented individuals. Unrepresented claimants who received deficiency notices got them by mail. Anyone who has changed their address should email purduepitrust@purduepitrust.com with their name and updated information.² The Trust can also be reached at (855) 637-5538.¹²

The filing deadline has passed, and the Trust has stated it will not provide individual award information or claim status updates until after the Effective Date. The next round of communications from the Trust should tell claimants whether their claim has been “deemed allowed” and what their payment amount will be. No firm date for those notifications has been announced.¹

1
Purdue PI Trust. Non-NAS PI Claim FAQs
2
Purdue PI Trust. Purdue Personal Injury Trust
3
California Lawyers Association. Purdue Pharma’s Plan Is Confirmed With Opt-In Releases of Sacklers
4
ProPublica. Purdue Settlement Leaves Opioid Victims Behind
5
Motley Byrne & Firm. Neonatal Abstinence Syndrome Ad Hoc Committee Objects to Sackler-Funded Plan
6
Maryland Office of the Attorney General. Attorney General Brown Announces Purdue Sackler $7.4 Billion Opioid Settlement to Go Into Effect
7
Pennsylvania Office of Attorney General. Purdue Sackler $7.4 Billion National Opioid Settlement Goes Into Effect
8
Massachusetts Attorney General. $7.4 Billion Settlement With Purdue Pharma and Sackler Family Goes Into Effect
9
The New York Times. Purdue Sacklers Settlement
10
Minnesota Attorney General. Opioid Settlement
11
Washington Attorney General. Purdue Pharma and Generic Manufacturers Settlements
12
Massachusetts Attorney General. Frequently Asked Questions About the Purdue Personal Injury Trust